We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Analysis of Saliva Provides Early Evidence of Oral Cancer

By Labmedica staff writers
Posted on 14 Apr 2008
A fibrous protein molecule known as cytokeratin 8 (CK8) in saliva is a potential cellular marker of premalignant changes in oral epithelial cells and of increased risk of cancer development.

Saliva samples were collected from eight subjects with oral cancer or a history of abnormal oral lesions and five healthy controls. More...
Participants brushed and rinsed with saline before providing the saliva sample containing cheek cells. Results showed that the percentage of cells with cytokeratin 8 was significantly higher in the cancer/abnormal samples than in samples from the normal controls.

Jennifer Frustino, a predoctoral student at the University at Buffalo School of Dental Medicine (Buffalo, NY, USA) and first author on the study, said that cytokeratin "has emerged recently as a potential cellular marker of premalignant changes in oral epithelial cells and of increased risk of cancer development. These markers are especially useful because they are abundant, stable, and easily stained and detected. Cytokeratin 8 expression is closely related to abnormalities of epithelial cells and shows a positive correlation with the development of head and neck squamous cell carcinoma.”

"This is the first study that detects CK8 as a biomarker through an easy collection method and simple analysis. The study is continuing and the results remain promising as more patients are enrolled.” concluded Ms. Faustino.

The preliminary study was conducted by investigators from the University of Buffalo, Roswell Park Cancer Institute (Buffalo, NY, USA) and Tufts University (Boston, MA, USAResults of the study were presented on April 4, 2008, at a poster session at the 2008 American Academy of Dental Research in Dallas (Texas, USA).


Related Links:
University at Buffalo School of Dental Medicine
Roswell Park Cancer Institute
Tufts University

Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.